MedTrace Logo

Allogenic Cord Blood Transfusion in Patients With Cerebral Palsy

NCT03826498 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-01-18

No results posted yet for this study

Summary

Cerebral palsy is a disorder of movement and posture resulted from a non-progressive lesion or injury of the immature brain. It is a leading cause of childhood onset disability.

Many experimental animal studies have revealed that umbilical cord blood is useful to repair neurological injury in brain.

On the basis of many experimental studies, umbilical cord blood is suggested as a potential therapy for cerebral palsy.

Conditions

  • Cerebral Palsy

Interventions

BIOLOGICAL

CP CB-MNC injection

CB-MNC injection from different donors. One dose consist 20-50 mil MNC/kg.The protocol include 3 injection at monthly intervals.

OTHER

Standard therapy

The standard therapy can include drugs, special psychology training etc.

Sponsors & Collaborators

  • State-Financed Health Facility "Samara Regional Medical Center Dinasty"

    lead OTHER

Principal Investigators

  • STANISLAV VOLCHKOV, MD, PhD · Medical Centre Dinasty

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-12
Primary Completion
2024-01-26
Completion
2024-12-26

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03826498 on ClinicalTrials.gov